Agilon Health (NYSE:AGL) Shares Up 5.4% – Here’s Why

Agilon Health, Inc. (NYSE:AGL)’s stock price was up 5.4% during trading on Thursday . The stock traded as high as $100.00 and last traded at $98.6820. Approximately 33,811 shares changed hands during trading, a decline of 90% from the average daily volume of 354,760 shares. The stock had previously closed at $93.64.

Analyst Ratings Changes

Several research firms have recently weighed in on AGL. TD Cowen restated a “hold” rating and issued a $55.00 target price (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. JPMorgan Chase & Co. downgraded Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective for the company. in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Finally, Robert W. Baird set a $116.00 target price on shares of Agilon Health in a report on Thursday, August 6th. Five research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $91.30.

Agilon Health Stock Performance

The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The stock’s fifty day simple moving average is $106.62 and its 200 day simple moving average is $60.12. The company has a market cap of $1.64 billion, a price-to-earnings ratio of -6.84 and a beta of 3.01.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.90. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. As a group, analysts anticipate that Agilon Health, Inc. will post -2.95 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. increased its stake in shares of Agilon Health by 196.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after acquiring an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares during the last quarter. North Peak Capital Management LLC grew its holdings in shares of Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after purchasing an additional 3,715,460 shares during the period. Voleon Capital Management LP grew its holdings in shares of Agilon Health by 5,519.2% in the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after purchasing an additional 2,692,259 shares during the period. Finally, UBS Group AG increased its position in Agilon Health by 250.7% during the fourth quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock worth $2,339,000 after purchasing an additional 2,427,136 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.